Every trauma surgeon has been there: you’re in the middle of a mangled extremity case, and the math doesn’t add up.
The patient’s tibial bone stock is too short for a functional below-knee amputation (BKA), but bumping the level to an above-knee amputation (AKA) feels like sentencing them to a lifetime of higher energy cost, worse gait, and fewer prosthetic options.
A recent JBJS Case Connector report offers a pragmatic way out of that corner: use a temporary antibiotic PMMA spacer to restore tibial length and preserve a transtibial level — “An Antibiotic Spacer May Be Used to Acquire Adequate Tibia Length for a Transtibial Amputation to Prevent the Need for a Transfemoral Amputation.”
The Case
- A 30-year-old motorcyclist arrives with a traumatic BKA and major posterior tibial bone loss.
- Instead of converting to a transfemoral amputation, the team hand-mixed an antibiotic cement spacer, molded it to restore tibial length and contour, and closed over it.
- At 2.5 years: the patient is fully weight bearing, pain-free, and using a prosthesis comfortably — no further interventions required.
Why It Matters
Losing a transtibial level to an AKA is a massive penalty. The metabolic cost of ambulation skyrockets, prosthetic choices narrow, and patient quality of life dips. If contamination is under control and soft tissue coverage is possible, a spacer buys back tibial length without the delays of bone transport, vascularized fibula, or staged reconstructions.
Technique Highlights
- Goal length: ≥12–15 cm from the tibial plateau is often cited as the sweet spot for a functional socket.
- Mixing: PMMA loaded with vancomycin, gentamicin, or per institutional protocol.
- Shaping: contour the spacer to recreate the posterior tibia, ensuring smooth transitions for soft tissue closure.
- Benefits: local antibiotic elution, radiopaque for follow-up imaging, and a stable scaffold for closure.
- Don’t forget: meticulous debridement, tension-free closure, and hawk-eyed infection surveillance.
Caveats
This is a single case report — no randomized trial, no comparative series. Long-term durability of leaving a spacer in situ is unknown. The trick only works if you’ve got adequate soft tissue coverage and controlled contamination at the index operation.
Bottom Line for Trauma Teams
When the only thing standing between your patient and an AKA is a few centimeters of missing tibia, a low-cost, off-the-shelf antibiotic spacer might just save the day. It’s simple, reproducible, and — at least in this case — delivered a functional, pain-free transtibial outcome at mid-term follow-up.
Sometimes, limb salvage isn’t about heroics. It’s about small, clever moves that keep patients walking on their own two feet.